MDT

98.5

+2.11%↑

A

146.08

-0.25%↓

VEEV

218.2

-4.44%↓

HQY

85.69

+1.95%↑

NEOG

9.39

+2.4%↑

MDT

98.5

+2.11%↑

A

146.08

-0.25%↓

VEEV

218.2

-4.44%↓

HQY

85.69

+1.95%↑

NEOG

9.39

+2.4%↑

MDT

98.5

+2.11%↑

A

146.08

-0.25%↓

VEEV

218.2

-4.44%↓

HQY

85.69

+1.95%↑

NEOG

9.39

+2.4%↑

MDT

98.5

+2.11%↑

A

146.08

-0.25%↓

VEEV

218.2

-4.44%↓

HQY

85.69

+1.95%↑

NEOG

9.39

+2.4%↑

MDT

98.5

+2.11%↑

A

146.08

-0.25%↓

VEEV

218.2

-4.44%↓

HQY

85.69

+1.95%↑

NEOG

9.39

+2.4%↑

Search

Quanterix Corp

Închisă

SectorSănătate

7.34 2.66

Rezumat

Modificarea prețului

24h

Curent

Minim

7.15

Maxim

7.43

Indicatori cheie

By Trading Economics

Venit

-3.5M

-34M

Vânzări

16M

40M

Marjă de profit

-83.479

Angajați

471

EBITDA

5.7M

-31M

Recomandări

By TipRanks

Recomandări

Neutru

Prognoză pe 12 luni

+4.75% upside

Dividende

By Dow Jones

Următoarele câștiguri

16 mar. 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

106M

344M

Deschiderea anterioară

4.68

Închiderea anterioară

7.34

Sentimentul știrilor

By Acuity

75%

25%

331 / 361 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Neutral Evidence

Quanterix Corp Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

14 ian. 2026, 22:41 UTC

Achiziții, Fuziuni, Preluări

Canadian Natural Resources, Tourmaline File Deal Notice With Antitrust Regulator

15 ian. 2026, 00:00 UTC

Câștiguri

Welcome to Greenland, an Economy Reliant on Subsidies and Shrimp -- WSJ

14 ian. 2026, 23:47 UTC

Market Talk

Oil Slips After Trump Appears to Tilt Away From Military Action in Iran -- Market Talk

14 ian. 2026, 23:44 UTC

Market Talk

Nikkei May Decline After Hitting Record Highs; Election in Focus -- Market Talk

14 ian. 2026, 23:39 UTC

Market Talk

ANZ's New Bull Still Sees Valuation Gap to Peers -- Market Talk

14 ian. 2026, 23:32 UTC

Market Talk

Gold Declines on Likely Technical Correction, Possible Profit-Taking -- Market Talk

14 ian. 2026, 22:56 UTC

Achiziții, Fuziuni, Preluări

Soho House Amends Rollover and Support Agreements With Broad Street Principal Investments and Others

14 ian. 2026, 22:53 UTC

Achiziții, Fuziuni, Preluări

Soho House: Apollo Global Management and Goldman Sachs Asset Management Amend Debt Commitment

14 ian. 2026, 22:17 UTC

Market Talk

Global Equities Roundup: Market Talk

14 ian. 2026, 22:17 UTC

Market Talk

WiseTech's Revenue Growth Drivers Attract Scrutiny -- Market Talk

14 ian. 2026, 22:09 UTC

Câștiguri

CITIC Securities: Uptrend in China Capital Markets Supported Results >600030.SH

14 ian. 2026, 22:08 UTC

Câștiguri

CITIC Securities 2025 Oper Rev CNY74.83B Vs. CNY58.12B >600030.SH

14 ian. 2026, 22:08 UTC

Câștiguri

CITIC Securities 2025 Net CNY30.05B Vs. Net CNY21.57B >600030.SH

14 ian. 2026, 21:53 UTC

Achiziții, Fuziuni, Preluări

WuXi XDC Expects 2025 Net to Increase Over 38% on Year

14 ian. 2026, 21:53 UTC

Achiziții, Fuziuni, Preluări

WuXi XDC Expects 2025 Revenue to Increase More Than 45% on Year

14 ian. 2026, 21:52 UTC

Achiziții, Fuziuni, Preluări

WuXi XDC Announces Positive Profit Alert for 2025

14 ian. 2026, 21:51 UTC

Achiziții, Fuziuni, Preluări

Citigroup Acting as Financial Advisor to WuXi XDC

14 ian. 2026, 21:51 UTC

Achiziții, Fuziuni, Preluări

WuXi XDC: Aims to Keep Listing Status of BioDlink

14 ian. 2026, 21:51 UTC

Achiziții, Fuziuni, Preluări

WuXi XDC: Company to Finance BioDlink Shares Acquisition via Internal Resources

14 ian. 2026, 21:50 UTC

Market Talk
Câștiguri

Financial Services Roundup: Market Talk

14 ian. 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

14 ian. 2026, 21:49 UTC

Achiziții, Fuziuni, Preluări

WuXi XDC: BioDlink Offer to Cost HK$2.79B

14 ian. 2026, 21:48 UTC

Achiziții, Fuziuni, Preluări

WuXi XDC Offers to Pay HK$4.00 for Each BioDlink International Share

14 ian. 2026, 21:48 UTC

Achiziții, Fuziuni, Preluări

WuXi XDC Makes Cash Offer for BioDlink International

14 ian. 2026, 21:13 UTC

Market Talk

Oil Retreats Late After Trump Comments on Iran -- Market Talk

14 ian. 2026, 20:30 UTC

Market Talk
Câștiguri

Danaher's Preliminary 4Q Seen as Promising -- Market Talk

14 ian. 2026, 20:13 UTC

Market Talk

U.S. Natural Gas Futures Sink Ahead of Storage Report -- Market Talk

14 ian. 2026, 20:08 UTC

Market Talk

Oil Futures Extend Rally on Iran Tensions -- Market Talk

14 ian. 2026, 19:33 UTC

Market Talk

Nutrien Seen as Winner in Tighter 2026 Potash Market, Higher Prices -- Market Talk

14 ian. 2026, 19:06 UTC

Market Talk
Câștiguri

Wells Fargo Says Customers, Economy Remain Resilient -- Market Talk

Comparație

Modificare preț

Quanterix Corp Așteptări

Obiectiv de preț

By TipRanks

4.75% sus

Prognoză pe 12 luni

Medie 7.5 USD  4.75%

Maxim 8 USD

Minim 7 USD

În baza a 2 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruQuanterix Corp - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

2 ratings

0

Cumpărare

2

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

5.34 / 6.015Suport & Rezistență

Termen scurt

Neutral Evidence

Termen mediu

Bullish Evidence

Termen lung

No Evidence

Sentiment

By Acuity

331 / 361 Clasament în Sănătate

Sentimentul știrilor

Evidențe foarte puternice de scădere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Quanterix Corp

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, it offers contract research services, including sample testing, homebrew assay development, custom assay development, lucent diagnostic, and LDT testing services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.
help-icon Live chat